Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Elimination af hepatitis C-virus i Danmark

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Orbital cysticercosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Presence of SARS-CoV-2 in semen and the impact of COVID-19 on the male reproductive system

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Behandling af mandlig infertilitet

    Research output: Contribution to journalReviewResearchpeer-review

  4. Kirurgisk behandling ved kvindelig infertilitet

    Research output: Contribution to journalReviewResearchpeer-review

  5. Dopaminergic drugs in the treatment of depression

    Research output: Contribution to journalReviewResearchpeer-review

  1. Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Mortality in patients with Chronic Hepatitis C and cirrhosis compared to the general population - a Danish cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Anna Døssing
  • Birgitte Thorup Røge
  • Lone Galmstrup Madsen
  • Alex Lund Laursen
  • Jesper Bach Hansen
  • Jens Bukh
  • Nina Weis
View graph of relations

In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.

Translated title of the contributionElimination of hepatitis C virus in Denmark
Original languageDanish
JournalUgeskrift for Laeger
Volume182
Issue number9
ISSN0041-5782
Publication statusPublished - 24 Feb 2020

ID: 62082623